-
1
-
-
56749180450
-
Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis
-
Dietze R, Hadad DJ, McGee B, et al. Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis. Am J Respir Crit Care Med 2008, 178:1180-1185.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 1180-1185
-
-
Dietze, R.1
Hadad, D.J.2
McGee, B.3
-
2
-
-
65649089528
-
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model
-
Williams KN, Stover CK, Zhu T, et al. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model. Antimicrob Agents Chemother 2009, 53:1314-1319.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1314-1319
-
-
Williams, K.N.1
Stover, C.K.2
Zhu, T.3
-
3
-
-
72049096404
-
Linezolid in the treatment of multidrug-resistant tuberculosis
-
Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 2010, 50:49-55.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 49-55
-
-
Schecter, G.F.1
Scott, C.2
True, L.3
Raftery, A.4
Flood, J.5
Mase, S.6
-
4
-
-
69249137544
-
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
-
Migliori GB, Eker B, Richardson MD, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J 2009, 34:387-393.
-
(2009)
Eur Respir J
, vol.34
, pp. 387-393
-
-
Migliori, G.B.1
Eker, B.2
Richardson, M.D.3
-
5
-
-
67650730258
-
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
-
Koh W-J, Kwon OJ, Gwak H, et al. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother 2009, 64:388-391.
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 388-391
-
-
Koh, W.-J.1
Kwon, O.J.2
Gwak, H.3
-
6
-
-
40549129680
-
Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis
-
Yew WW, Chau CH, Wen KH Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008, 12:345-346.
-
(2008)
Int J Tuberc Lung Dis
, vol.12
, pp. 345-346
-
-
Yew, W.W.1
Chau, C.H.2
Wen, K.H.3
-
7
-
-
84860330843
-
Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure patients in India
-
Singla R, Caminero JA, Jaiswal A, et al. Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure patients in India. Eur Respir J 2012, 39:956-962.
-
(2012)
Eur Respir J
, vol.39
, pp. 956-962
-
-
Singla, R.1
Caminero, J.A.2
Jaiswal, A.3
-
8
-
-
44449177016
-
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years
-
Huang T-S, Liu Y-C, Sy C-L, Chen Y-S, Tu H-Z, Chen B-C In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob Agents Chemother 2008, 52:2226-2227.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 2226-2227
-
-
Huang, T.-S.1
Liu, Y.-C.2
Sy, C.-L.3
Chen, Y.-S.4
Tu, H.-Z.5
Chen, B.-C.6
-
9
-
-
73949101816
-
Mechanisms of drug resistance in Mycobacterium tuberculosis
-
Zhang Y, Yew WW Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:1320-1330.
-
(2009)
Int J Tuberc Lung Dis
, vol.13
, pp. 1320-1330
-
-
Zhang, Y.1
Yew, W.W.2
-
10
-
-
34547424537
-
Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome
-
Narita M, Tsuji BT, Yu VL Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 2007, 27:1189-1197.
-
(2007)
Pharmacotherapy
, vol.27
, pp. 1189-1197
-
-
Narita, M.1
Tsuji, B.T.2
Yu, V.L.3
-
11
-
-
11244293686
-
Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong
-
Chang KC, Leung CC, Tam CM Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004, 8:1492-1498.
-
(2004)
Int J Tuberc Lung Dis
, vol.8
, pp. 1492-1498
-
-
Chang, K.C.1
Leung, C.C.2
Tam, C.M.3
-
12
-
-
33847699798
-
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is 'science' enough to tackle the epidemic?
-
Migliori GB, Loddenkemper R, Blasi F, Raviglione MC 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is 'science' enough to tackle the epidemic?. Eur Respir J 2007, 29:423-427.
-
(2007)
Eur Respir J
, vol.29
, pp. 423-427
-
-
Migliori, G.B.1
Loddenkemper, R.2
Blasi, F.3
Raviglione, M.C.4
-
13
-
-
0035992065
-
Hematologic effects of linezolid: summary of clinical experience
-
Gerson SL, Kaplan SL, Bruss JB, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002, 46:2723-2726.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 2723-2726
-
-
Gerson, S.L.1
Kaplan, S.L.2
Bruss, J.B.3
-
14
-
-
4043151561
-
Peripheral neuropathy associated with prolonged use of linezolid
-
Bressler AM, Zimmer SM, Gilmore JL, Somani J Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004, 4:528-531.
-
(2004)
Lancet Infect Dis
, vol.4
, pp. 528-531
-
-
Bressler, A.M.1
Zimmer, S.M.2
Gilmore, J.L.3
Somani, J.4
-
15
-
-
84864512573
-
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
-
published online May 8.
-
Koh W-J, Kang YR, Jeon K, et al. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J Antimicrob Chemother 2012, published online May 8. 10.1093/jac/dks078.
-
(2012)
J Antimicrob Chemother
-
-
Koh, W.-J.1
Kang, Y.R.2
Jeon, K.3
-
16
-
-
80053082369
-
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis
-
Villar M, Sotgiu G, D'Ambrosio L, et al. Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis. Eur Respir J 2011, 38:730-733.
-
(2011)
Eur Respir J
, vol.38
, pp. 730-733
-
-
Villar, M.1
Sotgiu, G.2
D'Ambrosio, L.3
-
17
-
-
84862735973
-
-
Extensively drug-resistant tuberculosis (XDR-TB) treated with daily/intermittent linezolid. Chicago, USA, 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, USA; Sept 17-20. L1-1488.
-
Chang KC, Yew WW, Cheung SW, Leung CC. Extensively drug-resistant tuberculosis (XDR-TB) treated with daily/intermittent linezolid. Chicago, USA, 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, USA; Sept 17-20, 2011. L1-1488.
-
(2011)
-
-
Chang, K.C.1
Yew, W.W.2
Cheung, S.W.3
Leung, C.C.4
-
18
-
-
33744503144
-
Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones
-
McKee EE, Ferguson M, Bentley AT, Marks TA Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother 2006, 50:2042-2049.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 2042-2049
-
-
McKee, E.E.1
Ferguson, M.2
Bentley, A.T.3
Marks, T.A.4
|